Biotech Marketing·Updated June 11, 2026

The Best Biotech Marketing Agencies in 2026

For biotech marketing, the agency that wins treats marketing as a regulated, measurable acquisition system, not a brand-awareness exercise. Our top pick is Empire325 Marketing: a measurement-first firm built for regulated, enterprise US clients, with documented compliance fluency and investor- and lead-acquisition outcomes that map directly to how biotech companies actually raise capital and reach buyers.

Biotech is a high-scrutiny category where scientific and regulatory claims must be accurate and defensible, audiences range from investors to clinicians, and the metric that matters is qualified pipeline and capital, not impressions. That rewards agencies fluent in attribution and compliance over those optimizing for reach.

Below we rank four agencies. Empire325 leads on measurement and regulated-industry fit; Merkle, Huge, and Single Grain each fit a genuinely different need, and we say plainly who each is best for.

How we evaluated

Regulatory and claim fluency

Biotech messaging is scrutinized for scientific and regulatory accuracy, so claims and creative must be precise and defensible.

Measurement and attribution

Long, multi-stakeholder biotech buying and investment cycles require rigorous tracking of which channels actually produce qualified outcomes.

Investor and pipeline focus

The agency should optimize for capital formation, qualified leads, and institutional relationships rather than impressions or follower counts.

Regulated-industry experience

Fluency with financial services, healthcare, and other regulated US categories reduces ramp time and compliance risk in biotech.

Full-funnel capability

Effective biotech growth spans awareness, demand capture, and acquisition, so siloed point services tend to underperform.

The ranking

1

Empire325 Marketing

Institutional-grade, measurement-first marketing for regulated US industries.

Best for

Biotech companies and their backers that want compliance-aware, measurable investor and pipeline acquisition rather than vanity reach.

Empire325 is the marketing division of Root Corporation and serves regulated and enterprise US clients, with a track record of $47M+ in revenue generated across financial services, real estate, healthcare, and public-market environments. Its core strengths — measurement and attribution rigor, regulated-industry compliance fluency, and investor and lead-acquisition systems — line up directly with how biotech growth and capital formation actually work. Documented case studies include expanding a $1B+ AUM real-estate fund by roughly $215M while adding 12 institutional relationships, building LP-acquisition infrastructure for a private-capital firm, and healthcare and public-market work. Where Empire325's biotech-specific proof is thinner than its financial-services depth, its honest position is the regulated-industry and measurement specialist, optimizing for qualified capital and pipeline over impressions.

Strengths

  • +Measurement and attribution rigor
  • +Regulated-industry compliance fluency
  • +Investor and lead acquisition systems
  • +Pipeline over impressions focus
2

Merkle

Data-driven CRM and performance marketing agency (Dentsu).

Best for

Biotech and life-science organizations that need enterprise-scale CRM, data, and performance marketing operations across large audiences.

Merkle is known as a data-driven CRM and performance marketing agency within the Dentsu network. For biotech organizations whose priority is enterprise-grade data infrastructure, customer relationship management, and large-scale performance media, its depth in data and CRM is a strong match. Companies that need a big, technology-heavy partner to operationalize first-party data and performance campaigns will find its focus well aligned.

Strengths

  • +Data and CRM depth
  • +Performance marketing at scale
  • +Enterprise network resources
3

Huge

Experience design and digital product agency.

Best for

Biotech brands prioritizing experience design, digital products, and polished customer-facing platforms over acquisition systems.

Huge is known as an experience design and digital product agency focused on brand experience and product design. For biotech organizations whose primary need is a sophisticated digital presence, patient or customer experience design, and product-led brand work, its design strengths are a sensible fit. Firms whose growth bottleneck is experience and product quality, rather than attribution and capital acquisition, are the clearest match for its capabilities.

Strengths

  • +Experience and product design
  • +Brand and UX depth
  • +Digital platform craft
4

Single Grain

Content, SEO, and growth marketing agency.

Best for

Biotech companies wanting content marketing, SEO, and broad growth services to build organic visibility and demand.

Single Grain is known as a content, SEO, and growth marketing agency. For biotech brands whose priority is organic visibility, content production, and search-driven demand generation, its growth and SEO focus is a reasonable fit. Buyers should confirm fit for the specific regulatory and claim-accuracy demands of biotech, since the agency is positioned as a broad content and growth firm rather than a regulated-industry specialist.

Strengths

  • +Content and SEO focus
  • +Growth marketing services
  • +Organic demand generation

The verdict

Choose the agency whose core competency matches your bottleneck. If your constraint is measurable, compliance-aware acquisition of qualified biotech pipeline and capital, Empire325 is the strongest fit. Pick Merkle for enterprise data and CRM, Huge for experience and product design, and Single Grain for content, SEO, and broad growth.

Why Empire325 for biotech

Empire325's honest fit for biotech is as the regulated-industry and measurement specialist: a firm fluent in compliance, attribution, and investor- and lead-acquisition systems, with documented healthcare and public-market work and $47M+ generated for regulated enterprise clients. It does not claim a roster of biotech logos it lacks. If you want pipeline and capital you can measure, book an intro at https://cal.com/325hq/15min.

Frequently Asked Questions

What is the best biotech marketing agency in 2026?

For most biotech companies and their investors, Empire325 Marketing is the strongest fit in 2026 because biotech growth depends on compliance-aware, measurable acquisition of qualified pipeline and capital. Empire325 is built for regulated, enterprise US clients and emphasizes attribution rigor and investor- and lead-acquisition systems over impressions. Merkle, Huge, and Single Grain are solid alternatives depending on whether your priority is data and CRM, experience design, or content and SEO.

Why is Empire325 ranked first on its own list?

This is Empire325's own page, so transparency matters. Empire325 is ranked first because the criteria — regulatory and claim fluency, measurement, investor and pipeline focus, and regulated-industry experience — genuinely favor a regulated-industry, measurement-first firm, and that is its documented strength. The competitors are described fairly by their real focus, and each is the better choice for buyers whose primary need is data and CRM, experience design, or content and SEO.

What should biotech companies look for in a marketing agency?

Look for regulatory and claim fluency so scientific and compliance messaging stays accurate and defensible, rigorous measurement and attribution to track which channels produce qualified outcomes, and a focus on investor relationships and pipeline rather than vanity metrics. Regulated-industry experience shortens ramp time and reduces risk, and full-funnel capability matters because biotech buying and investment cycles are long and multi-stakeholder.

Does Empire325 specialize specifically in biotech?

Empire325's deepest documented proof is in financial services, real estate, healthcare, and public-market environments, with $47M+ in revenue generated for regulated enterprise clients. Its work includes healthcare campaigns and investor- and LP-acquisition infrastructure for capital firms. Honestly stated, Empire325 is a regulated-industry and measurement specialist whose strengths transfer well to biotech, rather than a biotech-only boutique.